Susan L Koletar MD

Infectious Disease•Columbus, OH

HIV/AIDS Medicine

Professor, Internal Medicine, Ohio State University College of Medicine

Join to View Full Profile

410 W 10th AveFl 2Columbus, OH 43210
Phone+1 614-293-7677
Fax+1 614-293-5614

Education & Training

Ohio State University HospitalFellowship, Infectious Disease, 1986 - 1988
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1983 - 1986
West Virginia University School of MedicineClass of 1983

Certifications & Licensure

OH State Medical License 1986 - 2026
WV State Medical License 1984 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy Start of enrollment: 1997 Oct 01
Completed
Not Applicable
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
Completed
Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults Start of enrollment: 2005 Nov 01
Completed
Not Applicable
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women Start of enrollment: 2010 Jan 01
Completed
Phase 4
Respiratory Virus Hospitalization Study (FLU 003 Plus)
COMPLETED
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
Completed
Phase 4
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure Start of enrollment: 2014 Dec 01
Completed
Phase 3
PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) Start of enrollment: 2017 Mar 14
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

Utilization of an Off-Site Patient Navigator to Facilitate HIV Pre-Exposure Prophylaxis Referrals in Patients with Sexually Transmitted Infections in the Emergency Dep...
Ashley Lipps, Natalie Nielsen, Anne Dannemiller, Yesha Patel, Jose A Bazan
AIDS and Behavior. 2025-03-01
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection.
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, Sonya L Heath, Susan L Koletar
JCI Insight. 2025-02-24
2 citations
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study.
Sarah C Mann, Weiqun Tong, Alison G Abraham, Frank Palella, Anjali Sharma
AIDS. 2024-11-15

Journal Articles

The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with Human Immunodeficiency Virus...
C William Wester, Edgar Turner Overton, Susan L Koletar, Kristine M Erlandson, Constance A Benson, Robert C Kalayjian, Clinical Infectious Diseases

Press Mentions

What We Know About the Ohio Measles OutbreakJanuary 15th, 2023
Infectious Diseases Society of America Announces Next Editor-in-Chief of the Journal of Infectious DiseasesJanuary 11th, 2022
Number of Ohio COVID Cases near Same as Delta SurgeDecember 8th, 2021
Join now to see all

Grant Support

Pitt-Ohio State Clinical Trials UnitUNIVERSITY OF PITTSBURGH AT PITTSBURGH2007–2027
The Ohio State University AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
Safety, Tolerability, And Pharmacokinetic Interactions Of AtazanavirNational Center For Research Resources2008
Clinical Trial: HIV Treatment-Experienced Patients To Evaluate Pa103001-04National Center For Research Resources2008
Lopinavir/Ritonavir Pharmacokinetics In HIV-1National Center For Research Resources2006–2008
Safety, Tolerability, And Pharmacokinetic Interactions Of Atazanavir And RifampNational Center For Research Resources2006–2007
Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2002–2006
Randomized Multicenter Phase II Study Of Continuous Infusion ProleukinNational Center For Research Resources1995